Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12621001486819Phase 4Completed
Phase 4, randomised, double-blind trial in pulmonary infection comparing Azithromycin with Placebo (2 arms). Primary endpoint: Rate of lower respiratory tract infections. Started Dec 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12621001486819.